Viewing Study NCT03075761


Ignite Creation Date: 2025-12-24 @ 12:35 PM
Ignite Modification Date: 2025-12-27 @ 9:37 PM
Study NCT ID: NCT03075761
Status: COMPLETED
Last Update Posted: 2021-05-18
First Post: 2016-04-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Physical Activity in Children at Risk of Post-thrombotic Sequelae (PACT)
Sponsor: University of Texas Southwestern Medical Center
Organization:

Study Overview

Official Title: Physical Activity in Children at Risk of Post-thrombotic Sequelae: A Pilot Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2021-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PACT
Brief Summary: 'The PACT trial' is randomized pilot trial to demonstrate the feasibility and potential effectiveness of a personal "fitness tracker" to improve adherence to an activity regimen following an initial acute DVT in children.
Detailed Description: The feasibility of an innovative intervention of a validated fitness tracker, the Fitbit, to improve adherence to a 12-week activity regimen in a pilot randomized controlled trial (RCT) will be tested in 44 subjects with first, acute, proximal lower extremity deep vein thrombosis (DVT).

The primary outcomes will consist of a) feasibility indicators determined a priori (eligibility, consent, adherence, retention) and b) estimates of effect size associated with the prescribed activity regimen, by describing within-subject change in QoL and potential biomarkers of postthrombotic syndrome (PTS) pre and post intervention in each group.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
1K23HL132054-01 NIH None https://reporter.nih.gov/quic… View